KDM1A and breast carcinoma: In breast cancer, Histone Lysine-specific Demethylase 1 (LSD1) inhibitors increase the enrichment of H3K4me2 at the proximal element or core regions of the transcription start site on the PD-L1 promoter, increasing PD-L1 expression in TNBC cells.